A Study of the Safety, Tolerability and Pharmacokinetics of ABBV-368 as a Single Agent and Combination in Subjects With Locally Advanced or Metastatic Solid Tumors
Clinical trial NCT03071757 · COMPLETED
Trial details
- NCT number
- NCT03071757
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-21
- Primary completion
- 2022-04-13
- Enrollment
- 139
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.